Semiconductors
Compare Stocks
5 / 10Stock Comparison
BZAI vs AEHR vs CEVA vs SIFY vs GFAI
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Telecommunications Services
Security & Protection Services
BZAI vs AEHR vs CEVA vs SIFY vs GFAI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Telecommunications Services | Security & Protection Services |
| Market Cap | $223M | $2.79B | $810M | $1.15B | $10M |
| Revenue (TTM) | $13M | $49M | $108M | $41.45B | $72M |
| Net Income (TTM) | $-153M | $-11M | $-11M | $-1.50B | $-24M |
| Gross Margin | 12.9% | 30.2% | 87.2% | 34.2% | 15.1% |
| Operating Margin | -427.2% | -27.8% | -10.1% | 5.2% | -27.4% |
| Forward P/E | — | — | 67.3x | — | — |
| Total Debt | $2M | $11M | $6M | $39.51B | $3M |
| Cash & Equiv. | $2K | $25M | $18M | $5.00B | $22M |
BZAI vs AEHR vs CEVA vs SIFY vs GFAI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 24 | May 26 | Return |
|---|---|---|---|
| Blaize Holdings, In… (BZAI) | 100 | 12.2 | -87.8% |
| Aehr Test Systems (AEHR) | 100 | 548.8 | +448.8% |
| CEVA, Inc. (CEVA) | 100 | 106.9 | +6.9% |
| Sify Technologies L… (SIFY) | 100 | 555.2 | +455.2% |
| Guardforce AI Co., … (GFAI) | 100 | 33.0 | -67.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BZAI vs AEHR vs CEVA vs SIFY vs GFAI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BZAI plays a supporting role in this comparison — it may shine differently against other peers.
AEHR is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 70.3% 10Y total return vs SIFY's 141.0%
- +9.9% vs GFAI's -53.2%
CEVA is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 2.76, Low D/E 2.1%, current ratio 7.09x
SIFY carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 1.33, yield 0.0%
- Rev growth 11.9%, EPS growth -8.8%, 3Y rev CAGR 13.9%
- Beta 1.33, yield 0.0%, current ratio 0.96x
- 11.9% revenue growth vs BZAI's -59.7%
Among these 5 stocks, GFAI doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.9% revenue growth vs BZAI's -59.7% | |
| Quality / Margins | -3.6% margin vs BZAI's -11.5% | |
| Stability / Safety | Beta 1.33 vs AEHR's 4.77 | |
| Dividends | 0.0% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +9.9% vs GFAI's -53.2% | |
| Efficiency (ROA) | -1.8% ROA vs BZAI's -232.8%, ROIC 3.3% vs -91.5% |
BZAI vs AEHR vs CEVA vs SIFY vs GFAI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
BZAI vs AEHR vs CEVA vs SIFY vs GFAI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GFAI leads in 1 of 6 categories
SIFY leads 1 • AEHR leads 1 • BZAI leads 0 • CEVA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CEVA and SIFY each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SIFY is the larger business by revenue, generating $41.4B annually — 3115.5x BZAI's $13M. SIFY is the more profitable business, keeping -3.6% of every revenue dollar as net income compared to BZAI's -11.5%. On growth, BZAI holds the edge at +14.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $13M | $49M | $108M | $41.4B | $72M |
| EBITDAEarnings before interest/tax | -$33M | -$10M | -$7M | $8.1B | -$12M |
| Net IncomeAfter-tax profit | -$153M | -$11M | -$11M | -$1.5B | -$24M |
| Free Cash FlowCash after capex | -$58M | -$14M | -$6M | $0 | -$6M |
| Gross MarginGross profit ÷ Revenue | +12.9% | +30.2% | +87.2% | +34.2% | +15.1% |
| Operating MarginEBIT ÷ Revenue | -4.3% | -27.8% | -10.1% | +5.2% | -27.4% |
| Net MarginNet income ÷ Revenue | -11.5% | -22.7% | -10.5% | -3.6% | -32.9% |
| FCF MarginFCF ÷ Revenue | -4.4% | -28.1% | -6.0% | -9.2% | -8.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.2% | -26.5% | +4.3% | +2.5% | +3.6% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | -2.2% | -2.0% | -3.7% | +38.9% |
Valuation Metrics
GFAI leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $223M | $2.8B | $810M | $1.1B | $10M |
| Enterprise ValueMkt cap + debt − cash | $225M | $2.8B | $797M | $1.5B | -$9M |
| Trailing P/EPrice ÷ TTM EPS | -45.19x | -702.00x | -91.14x | -119.57x | -0.89x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 67.35x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 18.19x | — |
| Price / SalesMarket cap ÷ Revenue | 143.72x | 47.39x | 7.57x | 2.73x | 0.28x |
| Price / BookPrice ÷ Book value/share | 7.67x | 21.97x | 2.99x | 4.65x | 0.16x |
| Price / FCFMarket cap ÷ FCF | — | — | 1569.47x | — | — |
Profitability & Efficiency
SIFY leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CEVA delivers a -4.2% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-9 for BZAI. CEVA carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SIFY's 1.96x. On the Piotroski fundamental quality scale (0–9), CEVA scores 6/9 vs AEHR's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.7% | -8.5% | -4.2% | -7.7% | -69.7% |
| ROA (TTM)Return on assets | -2.3% | -7.5% | -3.7% | -1.8% | -50.2% |
| ROICReturn on invested capital | -91.5% | -3.0% | -2.3% | +3.3% | -41.6% |
| ROCEReturn on capital employed | -126.2% | -3.2% | -2.7% | +4.4% | -19.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 1 | 6 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.06x | 0.09x | 0.02x | 1.96x | 0.08x |
| Net DebtTotal debt minus cash | $1M | -$14M | -$13M | $34.5B | -$19M |
| Cash & Equiv.Liquid assets | $1,506 | $25M | $18M | $5.0B | $22M |
| Total DebtShort + long-term debt | $2M | $11M | $6M | $39.5B | $3M |
| Interest CoverageEBIT ÷ Interest expense | — | — | — | 0.82x | -167.24x |
Total Returns (Dividends Reinvested)
AEHR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AEHR five years ago would be worth $398,515 today (with dividends reinvested), compared to $46 for GFAI. Over the past 12 months, AEHR leads with a +991.6% total return vs GFAI's -53.2%. The 3-year compound annual growth rate (CAGR) favors AEHR at 50.7% vs GFAI's -60.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -11.6% | +311.8% | +50.4% | +29.2% | -26.3% |
| 1-Year ReturnPast 12 months | -27.4% | +991.6% | +59.5% | +264.2% | -53.2% |
| 3-Year ReturnCumulative with dividends | -87.8% | +242.3% | +31.6% | +113.4% | -93.8% |
| 5-Year ReturnCumulative with dividends | -87.8% | +3885.1% | -35.4% | -12.1% | -99.5% |
| 10-Year ReturnCumulative with dividends | -87.8% | +7029.7% | +27.2% | +141.0% | -99.5% |
| CAGR (3Y)Annualised 3-year return | -50.4% | +50.7% | +9.6% | +28.8% | -60.4% |
Risk & Volatility
Evenly matched — CEVA and SIFY each lead in 1 of 2 comparable metrics.
Risk & Volatility
SIFY is the less volatile stock with a 1.33 beta — it tends to amplify market swings less than AEHR's 4.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CEVA currently trades 96.7% from its 52-week high vs BZAI's 27.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.05x | 4.77x | 2.76x | 1.33x | 2.31x |
| 52-Week HighHighest price in past year | $6.76 | $102.48 | $34.87 | $17.85 | $1.50 |
| 52-Week LowLowest price in past year | $1.00 | $8.06 | $17.02 | $4.15 | $0.38 |
| % of 52W HighCurrent price vs 52-week peak | +27.1% | +89.1% | +96.7% | +89.0% | +31.5% |
| RSI (14)Momentum oscillator 0–100 | 48.5 | 67.6 | 78.9 | 56.7 | 47.0 |
| Avg Volume (50D)Average daily shares traded | 9.2M | 3.0M | 498K | 56K | 378K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: BZAI as "Buy", AEHR as "Hold", CEVA as "Buy", SIFY as "Buy". Consensus price targets imply -13.0% upside for CEVA (target: $29) vs -32.1% for AEHR (target: $62).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | — |
| Price TargetConsensus 12-month target | — | $62.00 | $29.33 | — | — |
| # AnalystsCovering analysts | 2 | 3 | 23 | 1 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.0% | — |
| Dividend StreakConsecutive years of raises | — | — | — | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — | $0.36 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% | +1.0% | 0.0% | 0.0% |
GFAI leads in 1 of 6 categories (Valuation Metrics). SIFY leads in 1 (Profitability & Efficiency). 2 tied.
BZAI vs AEHR vs CEVA vs SIFY vs GFAI: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is BZAI or AEHR or CEVA or SIFY or GFAI a better buy right now?
For growth investors, Sify Technologies Limited (SIFY) is the stronger pick with 11.
9% revenue growth year-over-year, versus -59. 7% for Blaize Holdings, Inc. (BZAI). Analysts rate Blaize Holdings, Inc. (BZAI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BZAI or AEHR or CEVA or SIFY or GFAI?
Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +38.
9%, compared to -99. 5% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: AEHR returned +70. 3% versus GFAI's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BZAI or AEHR or CEVA or SIFY or GFAI?
By beta (market sensitivity over 5 years), Sify Technologies Limited (SIFY) is the lower-risk stock at 1.
33β versus Aehr Test Systems's 4. 77β — meaning AEHR is approximately 260% more volatile than SIFY relative to the S&P 500. On balance sheet safety, CEVA, Inc. (CEVA) carries a lower debt/equity ratio of 2% versus 196% for Sify Technologies Limited — giving it more financial flexibility in a downturn.
04Which is growing faster — BZAI or AEHR or CEVA or SIFY or GFAI?
By revenue growth (latest reported year), Sify Technologies Limited (SIFY) is pulling ahead at 11.
9% versus -59. 7% for Blaize Holdings, Inc. (BZAI). On earnings-per-share growth, the picture is similar: Guardforce AI Co. , Limited grew EPS 88. 3% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, SIFY leads at 13. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BZAI or AEHR or CEVA or SIFY or GFAI?
Sify Technologies Limited (SIFY) is the more profitable company, earning -2.
0% net margin versus -39. 4% for Blaize Holdings, Inc. — meaning it keeps -2. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIFY leads at 5. 7% versus -30. 7% for BZAI. At the gross margin level — before operating expenses — CEVA leads at 88. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is BZAI or AEHR or CEVA or SIFY or GFAI more undervalued right now?
Analyst consensus price targets imply the most upside for CEVA: -13.
0% to $29. 33.
07Which pays a better dividend — BZAI or AEHR or CEVA or SIFY or GFAI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is BZAI or AEHR or CEVA or SIFY or GFAI better for a retirement portfolio?
For long-horizon retirement investors, Sify Technologies Limited (SIFY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+141.
0% 10Y return). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SIFY: +141. 0%, GFAI: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BZAI and AEHR and CEVA and SIFY and GFAI?
These companies operate in different sectors (BZAI (Technology) and AEHR (Technology) and CEVA (Technology) and SIFY (Communication Services) and GFAI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.